View from the Thoraxcenter: AHA 23 Late-breaking Science Preview

Published: 09 Nov 2023

  • Views:

    Views Icon 478
  • Likes:

    Heart Icon 1
Average (ratings)
No ratings
Your rating

What should you keep an eye out for at this year's AHA Scientific Sessions? 

Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) return with their 'View from the Thoraxcenter' preview to highlight late-breaking and featured science trials being presented at this year's AHA Scientific Sessions. Join this dynamic discussion on some of the most anticipated data releases. 

The preview includes:

00:27 - DAPA-MI: A Registry-Based Randomized Trial of Dapagliflozin in Patients with Acute Myocardial Infarction Without Diabetes 

02:16 - ORBITA-2: Percutaneous Coronary Intervention for Stable Angina: A Randomised, Placebo-Controlled Trial 

05:14 - ECLS-SHOCK: Impact of Cardiac Arrest Before Randomization on the Efficacy of ECLS in Patients With Infarct-Related Cardiogenic Shock. A Sub-Analysis of the Prospective ECLS-Shock Trials 

09:07 - Ultrasound-assisted Catheter-directed Thrombolysis Versus Surgical Pulmonary Embolectomy for Intermediate-high Or High-risk Pulmonary Embolism: A Randomized Phase II Non-inferiority Study 

Stay tuned for our #AHA23 coverage from Philadelphia.


You must be to comment. If you are not registered, you can register here.